336 related articles for article (PubMed ID: 30565711)
41. Recent advances in non-invasive fetal HPA-1a typing.
Nogués N
Transfus Apher Sci; 2020 Feb; 59(1):102708. PubMed ID: 31953107
[TBL] [Abstract][Full Text] [Related]
42. Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.
Kjær M; Tiller H; Heide G; Kjeldsen-Kragh J; Skogen B; Husebekk A
PLoS One; 2017; 12(8):e0182957. PubMed ID: 28837581
[TBL] [Abstract][Full Text] [Related]
43. Maternal alloimmune antibodies against HPA and HLA class I antigens are associated with reduced birthweight among healthy neonates delivered by Chinese women.
Xue Y; Xin W; Li C; Zeng X; Song Z; Cao C; Zhao T
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1215-1219. PubMed ID: 35871773
[TBL] [Abstract][Full Text] [Related]
44. Fetal and neonatal alloimmune thrombocytopenia - The Norwegian management model.
Tiller H; Ahlen MT; Akkök ÇA; Husebekk A
Transfus Apher Sci; 2020 Feb; 59(1):102711. PubMed ID: 31911047
[TBL] [Abstract][Full Text] [Related]
45. HLA antibodies in fetal and neonatal alloimmune thrombocytopenia.
Colvin ZA; Schiller J; Tsaih SW; Sharma R; Grace RF; McIntosh JJ; Curtis BR
Transfusion; 2023 Jun; 63(6):1141-1149. PubMed ID: 37038316
[TBL] [Abstract][Full Text] [Related]
46. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia.
Bertrand G; Martageix C; Jallu V; Vitry F; Kaplan C
J Thromb Haemost; 2006 Mar; 4(3):628-37. PubMed ID: 16460445
[TBL] [Abstract][Full Text] [Related]
47. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
48. A combined effect of anti-HPA-1a and anti-HLA Class I in pregnancy?
Dahl J; Skogen B; Kjaer M; Husebekk A; Kjeldsen-Kragh J; Tiller H
Transfusion; 2020 Sep; 60(9):2121-2129. PubMed ID: 32608103
[TBL] [Abstract][Full Text] [Related]
49. The first reported case of neonatal alloimmune thrombocytopenia due to low-frequency human platelet antigen-6b antibodies in the United Kingdom.
Hopkins M; Brookes J; Watson D; Wroe E; Guthrie P; Horler J; Anayattil K; Calvert A; Poles A
Transfusion; 2021 Sep; 61(9):2788-2794. PubMed ID: 34156106
[TBL] [Abstract][Full Text] [Related]
50. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
Jackson DJ; Eastlake JL; Kumpel BM
Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
[TBL] [Abstract][Full Text] [Related]
51. Neonatal alloimmune thrombocytopenia due to anti-HPA 5a in a HPA-5a homozygous neonate.
Porta R; Serrano P; Paltrinieri A; Ristic G; Canals C; Lozano M
Transfus Apher Sci; 2020 Dec; 59(6):102880. PubMed ID: 32763115
[TBL] [Abstract][Full Text] [Related]
52. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
53. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
[TBL] [Abstract][Full Text] [Related]
54. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
[TBL] [Abstract][Full Text] [Related]
55. Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.
Husebekk A; El Ekiaby M; Gorgy G; Killie MK; Uhlin-Hansen C; Salma W; Navarrete C; El Afandi M; Skogen B; Ahlen MT
Transfus Apher Sci; 2012 Dec; 47(3):277-82. PubMed ID: 22640833
[TBL] [Abstract][Full Text] [Related]
56. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.
Ghevaert C; Campbell K; Stafford P; Metcalfe P; Casbard A; Smith GA; Allen D; Ranasinghe E; Williamson LM; Ouwehand WH
Transfusion; 2007 Jul; 47(7):1296-305. PubMed ID: 17581167
[TBL] [Abstract][Full Text] [Related]
57. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
Kjeldsen-Kragh J; Ahlen MT
Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
[TBL] [Abstract][Full Text] [Related]
58. Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia.
Szittner Z; Bentlage AEH; Temming AR; Schmidt DE; Visser R; Lissenberg-Thunnissen S; Mok JY; van Esch WJE; Sonneveld ME; de Graaf EL; Wuhrer M; Porcelijn L; de Haas M; van der Schoot CE; Vidarsson G
Front Immunol; 2023; 14():1225603. PubMed ID: 37868955
[TBL] [Abstract][Full Text] [Related]
59. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
[TBL] [Abstract][Full Text] [Related]
60. Maternal incompatibilities with fetal human platelet alloantigens -1a, -1b and -15 are the main causes of neonatal alloimmune thrombocytopenia in Russia.
Khaspekova SG; Golovkina LL; Donush EK; Golubeva NV; Shustova ON; Mazurov AV
Ter Arkh; 2018 Aug; 90(7):65-69. PubMed ID: 30701924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
